Carregant...
COVID‐19 convalescent plasma donor characteristics, product disposition, and comparison with standard apheresis donors
BACKGROUND: With coronavirus disease 2019 (COVID‐19) convalescent plasma (CCP) offering an early treatment option for COVID‐19, blood collectors needed to quickly overcome obstacles to recruiting and qualifying eligible donors. We provide attributes of CCP donors and products and compare to standard...
Guardat en:
| Publicat a: | Transfusion |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8013318/ https://ncbi.nlm.nih.gov/pubmed/33458811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.16286 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|